Presented at the International Society of Addiction Medicine (ISAM) annual meeting, Oslo, Norway, September 6-10, 2011
Louise F. Haynes, MSW (Lexington/Richland Alcohol and Drug Abuse Council, SC Node).
This presentation provides an overview of National Drug Abuse Treatment Clinical Trials Network protocol CTN-0032, which examined the efficacy of on-site rapid HIV testing with risk-reduction counseling in increasing receipt of HIV test results and reducing HIV risk behaviors among persons in drug treatment. The study demonstrated the value of on-site rapid HIV testing in drug treatment centers but found no additional benefit from HIV sexual risk-reduction couseling. A follow-up study examining the cost-effectiveness of on-site testing (CTN-0032-A-1) found that referral for off-site testing is less costly, but also less efficient -- the study determined that on-site testing is cost-effective, in that cast, using the current US threshold of <$100,000/QALY. Because on-site risk reduction counseling did not reduce sexual risk behavior or increase acceptance of HIV testing, it was not found to be cost-effective. (Presentation, PowerPoint slides, English, 2011)
Keywords: Community health services | Cost-effectiveness | HIV rapid testing | HIV/AIDS | Sexual risk behavior | Sexually transmitted diseases | International Society of Addiction Medicine (ISAM) annual meeting, 2011
Document No: 752
Submitted by CTN Dissemination Librarians, 9/20/2011.